← Open Payments lookup

MELISSA SAULS: Open Payments

NPI 1063065050 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,897 in 194 payments from 13 companies in 2025. Trend: 2023 $3,451 · 2024 $4,977 · 2025 $3,897

Food & beverage: $3,897
CompanyPaymentsAmount
QOL Medical, LLC16$520
Takeda Pharmaceuticals U.S.A., Inc.24$495
Janssen Biotech, Inc.21$397
ABBVIE INC.17$389
Salix Pharmaceuticals, a division of Bausch Health US, LLC43$363
Celltrion USA Inc.18$276
Lilly USA, LLC8$266
GENZYME CORPORATION9$249
Aimmune Therapeutics, Inc.13$228
Ardelyx, Inc.10$208

Products named: Sucraid, TREMFYA, XIFAXAN, ENTYVIO, VEGZELMA, OMVOH, DUPIXENT, ZENPEP.

Industry payments across TX — which companies pay providers there.